Erbin Inhibited Angiogenesis in vitro with the Inhibition on theSTAT3 Pathway in Breast Cancer Cells
It can be concluded that Erbin, with inhibiting the STAT3 pathway, suppresses the proangiogenic effects of breast cancer cells, thereby suggesting its potential as a therapeutic target for breast cancer.
Authors
- Yukan Li (ORCID: https://orcid.org/0009-0004-9451-8114)
- Yuling Sun (ORCID: https://orcid.org/0000-0001-5289-4673)
- Lixin Sun (ORCID: https://orcid.org/0000-0001-8203-0841)
- Hailan Xu
- Xinyang Li
- Xing Zhao (ORCID: https://orcid.org/0000-0002-7067-5754)
- Lingling Wang (ORCID: https://orcid.org/0000-0001-7458-7295)
- mingming zhao (ORCID: https://orcid.org/0000-0003-2092-9928)
- Die Mu
Institutions
- Chengde Medical University (CN)
Publication Details
- Journal
- Current Medicinal Chemistry
- Published
- 2025-04-23
- DOI
- https://doi.org/10.2174/0109298673366195250331175911
- Primary Topic
- Kruppel-like factors research
- Type
- article
- Field-Weighted Citation Impact
- 0.00